[1]
Akhter, P. et al. 2026. Role of 18F-FDG PET/CT in Assessment of Recurrence and Metastases in Female Breast Carcinoma Patients in Relation to Immunohistochemical Markers: Emphasis on HER2 Status, SUVmax Correlation, and Alignment with 2025/2026 EANM/SNMMI Guidelines. Bangladesh Journal of Nuclear Medicine. 29, 1 (May 2026), 28–35. DOI:https://doi.org/10.3329/bjnm.v29i1.89278.